VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_19-vv-00734 Package ID: USCOURTS-cofc-1_19-vv-00734 Petitioner: Kathryn Larson Filed: 2019-05-17 Decided: 2024-02-22 Vaccine: Tdap Vaccination date: 2016-08-01 Condition: Transverse Myelitis Outcome: compensated Award amount USD: 165000 AI-assisted case summary: Kathryn Larson filed a petition on May 17, 2019, alleging that she suffered Transverse Myelitis (TM) as a result of her Tetanus-diphtheria-acellular pertussis (Tdap) vaccination administered on August 1, 2016. Ms. Larson claimed that she experienced residual effects from the condition for more than six months, that there had been no prior award or settlement of a civil action for damages related to her condition, and that her vaccine was administered in the United States. The respondent, the Secretary of Health and Human Services, denied that the Tdap vaccine caused any of petitioner’s alleged injuries or her current condition. Despite the respondent's denial, the parties filed a joint stipulation on February 22, 2024, agreeing that compensation should be awarded. Special Master Daniel T. Horner reviewed the stipulation and found it reasonable, adopting it as the decision of the Court. Pursuant to the stipulation, Ms. Larson was awarded a lump sum of $165,000.00, payable by check to the petitioner. This amount is intended to compensate for all items of damages available under the Vaccine Act. The decision was entered on February 22, 2024. Petitioner was represented by Ronald Craig Homer of Conway, Homer, P.C., and respondent was represented by Naseem Kourosh of the U.S. Department of Justice. The public decision does not describe the specific onset of symptoms, clinical details of the condition, diagnostic tests performed, treatments received, or the specific mechanism by which the vaccine allegedly caused the injury. The public decision also does not name any medical experts. Theory of causation field: Petitioner Kathryn Larson alleged that her August 1, 2016 Tdap vaccination caused Transverse Myelitis (TM), with residual effects lasting more than six months. Respondent denied causation. The parties filed a joint stipulation on February 22, 2024, agreeing to an award of compensation. Special Master Daniel T. Horner adopted the stipulation, awarding petitioner a lump sum of $165,000.00. The public decision does not specify the theory of causation, name any experts, describe the medical mechanism, or detail the evidence considered. The award was based on a stipulation, not a finding of causation after litigation. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_19-vv-00734-0 Date issued/filed: 2024-03-18 Pages: 7 Docket text: PUBLIC DECISION (Originally filed: 2/22/2024) regarding 93 DECISION Stipulation/Proffer. Signed by Special Master Daniel T. Horner. (sh). Service on parties made. -------------------------------------------------------------------------------- Case 1:19-vv-00734-UNJ Document 97 Filed 03/18/24 Page 1 of 7 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 19-734V Filed: February 22, 2024 KATHRYN LARSON, Petitioner, v. SECRETARY OF HEALTH AND HUMAN SERVICES, Respondent. Ronald Craig Homer, Conway, Homer, P.C., Boston, MA, for petitioner. Naseem Kourosh, U.S. Department of Justice, Washington, DC, for respondent. DECISION ON JOINT STIPULATION1 On May 17, 2019, petitioner filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,2 (the “Vaccine Act”). Petitioner alleges that she suffered Transverse Myelitis (“TM”) as a result of her August 1, 2016 Tetanus-diphtheria-acellular pertussis (“Tdap”) vaccination. Petition at 1; Stipulation, filed February 22, 2024, at ¶ 4. Petitioner further alleges that she has experienced the residual effects of her condition for more than six months, that there has been no prior award or settlement of a civil action for damages as a result of her condition, and that her vaccine was administered in the United States. Petition at 1-2; Stipulation at ¶¶ 3-5. “Respondent denies that the Tdap vaccine caused any of petitioner’s alleged injuries or any other injury or petitioner’s current condition. ” Stipulation at ¶ 6. Nevertheless, on February 22, 2024, the parties filed the attached joint stipulation, stating that a decision should be entered awarding compensation. I find the 1 Because this document contains a reasoned explanation for the action taken in this case, it must be made publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the document will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). Case 1:19-vv-00734-UNJ Document 97 Filed 03/18/24 Page 2 of 7 stipulation reasonable and adopt it as the decision of the Court in awarding damages, on the terms set forth therein. Pursuant to the terms stated in the attached Stipulation, I award the following compensation: A lump sum of $165,000.00 in the form of a check payable to petitioner. Stipulation at ¶ 8. This amount represents compensation for all items of damages that would be available under § 15(a). Id. In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the court is directed to enter judgment in accordance with this decision.3 IT IS SO ORDERED. s/Daniel T. Horner Daniel T. Horner Special Master 3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice renouncing the right to seek review. 2 Case 1:19-vv-00734-UNJ Document 97 Filed 03/18/24 Page 3 of 7 Case 1:19-vv-00734-UNJ Document 97 Filed 03/18/24 Page 4 of 7 Case 1:19-vv-00734-UNJ Document 97 Filed 03/18/24 Page 5 of 7 Case 1:19-vv-00734-UNJ Document 97 Filed 03/18/24 Page 6 of 7 Case 1:19-vv-00734-UNJ Document 97 Filed 03/18/24 Page 7 of 7